Sarepta Therapeutics Inc (SRPT)

NASDAQ
122.89
-1.58(-1.27%)
After Hours
120.99
-1.90(-1.55%)
- Real-time Data
  • Volume:
    724,377
  • Day's Range:
    121.89 - 126.11
  • 52 wk Range:
    61.28 - 134.08

SRPT Overview

Prev. Close
124.47
Day's Range
121.89-126.11
Revenue
674.59M
Open
124.53
52 wk Range
61.28-134.08
EPS
-8.22
Volume
724,377
Market Cap
10.79B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
939,706
P/E Ratio
-14.83
Beta
1.08
1-Year Change
76.34%
Shares Outstanding
87,782,576
Next Earnings Date
Feb 28, 2023
What is your sentiment on Sarepta?
or
Market is currently closed. Voting is open during market hours.

Sarepta Therapeutics Inc News

Sarepta Therapeutics Inc Analysis

Sarepta Therapeutics Inc Company Profile

Sarepta Therapeutics Inc Company Profile

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company. The Company is focused on helping patients through the discovery and development of ribonucleic acid (RNA)-targeted therapeutics, gene therapy and other genetic therapeutic modalities for the treatment of rare diseases. It is developing therapeutic candidates for a range of diseases and disorders, including Duchenne muscular dystrophy (Duchenne), Limb-girdle muscular dystrophies (LGMDs) and other neuromuscular and central nervous system (CNS) disorders. It commercializes three products, such as EXONDYS 51 (eteplirsen) Injection, VYONDYS 53 (golodirsen) Injection and AMONDYS 45 (casimersen) Injection. These commercial products are indicated for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51, exon 53 and exon 45 skipping. Its pipeline includes more than 40 programs at various stages of discovery, pre-clinical and clinical development.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuySellSellNeutralStrong Buy
Technical IndicatorsStrong BuyBuyStrong SellStrong SellStrong Buy
SummaryStrong BuyNeutralStrong SellSellStrong Buy
  • 120+ very soon
    7
    • Huge Discount BUY BUY BUY!!!
      3
      • Good timing
        0
    • Target is 82$
      2
      • this company is trash
        0
        • On the 19th you said it will hit 100s, make up your mind
          0
        • it will but looks like it will take 3 months. But I added 100 lots more.
          0
        • I was hopeful it would bounce from the over reaction, bought at $91 after the dip...playing the long game now, but painful right now
          0
      • Going big.
        0
        • market is ********up right now. just wait couple months and it will hit 100s
          0
          • Sell on the news
            0
            • link?
              0
          • 115 !!!
            0
            • Buy. Target 115-120$
              0
              • arkg buy yesterday
                0